ReviewDrugs2021

Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

Niklas Huntemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.